U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H9N2O3.Na
Molecular Weight 216.1691
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMINOHIPPURATE SODIUM

SMILES

[Na+].NC1=CC=C(C=C1)C(=O)NCC([O-])=O

InChI

InChIKey=UNZMYCAEMNVPHX-UHFFFAOYSA-M
InChI=1S/C9H10N2O3.Na/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13;/h1-4H,5,10H2,(H,11,14)(H,12,13);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C9H9N2O3
Molecular Weight 193.1794
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Aminohippurate (p-aminohippuric acid, PAH, PAHA) is the glycine amide of p-aminobenzoic acid. Aminohippuric acid sodium salt is an agent to measure effective renal plasma flow (ERPF).

CNS Activity

Curator's Comment: The CNS penetration was shown in rats only.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
AMINOHIPPURATE SODIUM

Approved Use

Estimation of effective renal plasma flow. Measurement of the functional capacity of the renal tubular secretory mechanism.

Launch Date

1944
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
250 μg/mL
30 mg/kg single, intravenous
dose: 30 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
AMINOHIPPURIC ACID plasma
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
880 μg × min/mL
30 mg/kg single, intravenous
dose: 30 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
AMINOHIPPURIC ACID plasma
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: FED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
5.67 min
30 mg/kg single, intravenous
dose: 30 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
AMINOHIPPURIC ACID plasma
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: FED
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer







Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
yes [IC50 8.8 uM]
yes (co-administration study)
Comment: co-administered with adefovir as substrate. See https://pubmed.ncbi.nlm.nih.gov/24747579/
yes [Ki 19.6 uM]
yes (co-administration study)
Comment: co-administered with benzylpenicillin as substrate. See https://pubmed.ncbi.nlm.nih.gov/24747579/
Drug as victim
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Transport of ochratoxin A by renal multispecific organic anion transporter 1.
1999 Jun
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.
1999 May 7
Renal function of children exposed to cyclosporin in utero.
2000 Oct
Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers.
2001 Apr
Inducible nitric oxide synthase and glomerular hemodynamics in rats with liver cirrhosis.
2001 Aug
Long-term follow-up of renal function in recipients and donors following pediatric kidney transplantation.
2001 Dec
Net flux of folates and vitamin B12 through the gastrointestinal tract and the liver of lactating dairy cows.
2001 Dec
Alternative high-performance liquid chromatographic assay for p-aminohippuric acid (PAH): effect of aging on PAH excretion in the isolated perfused rat kidney.
2001 Dec
Effect of familial hypertension on glomerular hemodynamics and tubulo-glomerular feedback after uninephrectomy.
2001 Feb
Modulation by cyclic AMP and phorbol myristate acetate of cephaloridine-induced injury in rat renal cortical slices.
2001 Jan
Ambulatory blood pressure and heart rate in relation to kidney structure and metabolic control in adolescents with Type I diabetes.
2001 Jul
High-throughput multi-analyte screening for renal disease using capillary electrophoresis.
2001 Jul
Effects of different nickel compounds on the transport of para-aminohippurate ion by rat renal cortical slices.
2001 Jul 6
Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.
2001 Jun
Modulation of the basolateral and apical step of transepithelial organic anion secretion in proximal tubular opossum kidney cells. Acute effects of epidermal growth factor and mitogen-activated protein kinase.
2001 May 4
The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients.
2001 May-Jun
Cationic amino acids involved in dicarboxylate binding of the flounder renal organic anion transporter.
2001 Oct
Characterization of the mechanisms involved in the gender differences in p-aminohippurate renal elimination in rats.
2001 Sep
Increased renal tubular sodium reabsorption during exercise-induced hypervolemia in humans.
2001 Sep
Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells.
2001 Sep
Sex differences in p-aminohippuric acid transport in rat kidney: role of membrane fluidity and expression of OAT1.
2002 Apr
Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humans.
2002 Apr
Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.
2002 Feb
Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.
2002 Jan
Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit.
2002 Jul 5
Pharmacological characterization of the ATP-dependent low K(m) guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes.
2002 Mar 1
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
2002 May
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.
2002 May
Patents

Sample Use Guides

6 to 10 mg/kg
Route of Administration: Intravenous
The hOAT1-transformed cells were incubated in 200 ml of Dulbecco's PBS containing 5 mM D-glucose, 10 uM D-[3H]-mannitol and 10 uM [14C]-aminohippuric acid, for 10 min at room temperature.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:19:47 GMT 2023
Edited
by admin
on Fri Dec 15 16:19:47 GMT 2023
Record UNII
SUO3KVS1O9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMINOHIPPURATE SODIUM
ORANGE BOOK   USP   VANDF   WHO-DD  
Systematic Name English
AMINOHIPPURATE
VANDF  
Systematic Name English
SODIUM P-AMINOHIPPURATE [JAN]
Common Name English
.RHO.-AMINOHIPPURIC ACID SODIUM SALT [MI]
Common Name English
Aminohippurate sodium [WHO-DD]
Common Name English
P-AMINOHIPPURATE
Common Name English
MONOSODIUM P-AMINOHIPPURATE
Common Name English
AMINOHIPPURATE SODIUM [ORANGE BOOK]
Common Name English
AMINOHIPPURATE SODIUM [USP IMPURITY]
Common Name English
AMINOHIPPURATE [VANDF]
Common Name English
SODIUM P-AMINOHIPPURATE
JAN  
Common Name English
GLYCINE, N-(4-AMINOBENZOYL)-, MONOSODIUM SALT
Common Name English
AMINOHIPPURATE SODIUM [VANDF]
Common Name English
.RHO.-AMINOHIPPURIC ACID SODIUM SALT
MI  
Common Name English
SODIUM AMINOHIPPURATE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C1937
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
Code System Code Type Description
RXCUI
42837
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
ALTERNATIVE
RXCUI
203194
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
CAS
94-16-6
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
PUBCHEM
443971
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
CHEBI
64703
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
NCI_THESAURUS
C47392
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
FDA UNII
SUO3KVS1O9
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
CHEBI
104011
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
DRUG BANK
DB00345
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
EVMPD
SUB12851MIG
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
SMS_ID
100000077687
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
CHEBI
31204
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID40916717
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
ECHA (EC/EINECS)
202-309-8
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
ChEMBL
CHEMBL463
Created by admin on Fri Dec 15 16:19:47 GMT 2023 , Edited by admin on Fri Dec 15 16:19:47 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY